Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast cancer growth. Miller KD, Pniewski K, Perry CE, Papp SB, et al. Cancer Res 2021 Jan 7. pii: 0008-5472.CAN-20-1847.

Read + Share

Amedeo Smart

Independent Medical Education

Miller KD, Pniewski K, Perry CE, Papp SB, et al. Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast cancer growth. Cancer Res 2021 Jan 7. pii: 0008-5472.CAN-20-1847.
PMID: 33414169